Table 1. Demographics and group characteristics.
Controls | RR | SP | PP | All-MS | |
Number of subjects | 24 | 27 | 26 | 18 | 71 |
Age [years] | 36.0 (9.5) | 35.1 (7.3) | 41.7 (5.1) | 41.2 (6.5) | 39.1 (7.0) |
Disease duration [years] | - | 6.9 (4.2) | 14.3 (6.1) | 6.7 (3.1) | 9.5 (6.0) |
Median EDSS (range) | - | 2 (0.0–6.0) | 4.8 (2.5–7.0) | 4.0 (2.5–7.0) | 4.0 (0.0–7.0) |
ROI T2-LL (%) | - | 19.7 (11.3) | 28.9 (15.2) | 39.0 (20.6) | 28.0 (17.1) |
Brain T2-LL (%) | - | 0.14(0.09) | 0.29(0.24) | 0.61(0.33) | 0.60(0.41) |
Values are expressed as mean (Standard deviation).
RR: relapsing remitting; SP: secondary progressive; PP: primary progressive; EDSS: expanded disability status scale; ROI T2-LL: T2-lesion load corresponding to the lesion volume measured within the region of interest (ROI); Brain T2-LL: T2-lesion load corresponding to the lesion volume measured in the whole brain.